ETFChannel.com
ProShares Ultra Nasdaq Biotechnology

Fund Name:
ProShares Ultra Nasdaq Biotechnology
Issuer:
ProShares
Total Net Assets:
$82,214,000
Inception:
4/7/10
Related Index:
NASDAQ Biotechnology Index
ETF Category: 
Health - Leveraged
Expense Ratio: 
0.95 
Net Asset Value: 
$44.44  
Number of Holdings: 
367  
Annualized Yield: 
0.00%  
Annualized Distribution: 
NA  
Stock Weight Amount
Gilead Sciences 8.24% $6,775,972
Amgen 7.88% $6,480,700
Regeneron Pharmaceuticals 7.77% $6,390,214
Vertex Pharmaceuticals 7.63% $6,271,661
Moderna 4.96% $4,076,154
List of all 364 stocks held by BIB »
Future Weight Contracts
Proqr Therapeutics NV 0.04% 10,020
Quotes delayed 20 minutes

Email EnvelopeFree BIB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.09 out of 4)
0th percentile
(ranked lower than approx. 100% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
Shares Short 10,067
Chg. from Last Month -3,167
Shares Outstanding 1,850,000
% of Shares Short 0.54%
Days to Cover 0.3
Based on third party short interest data.

BIB | ProShares Ultra Nasdaq Biotechnology | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.